News - North America

Filter

Current filters:

North America

Popular Filters

1883 to 1898 of 1898 results

US FTC finds 60% rise in pharma pay-for-delay deals; flawed understanding says GPhA

05-05-2011

Pharmaceutical companies in the USA struck an unprecedented number of deals in fiscal year 2010 in which…

GenericsLicensingNorth AmericaPharmaceutical

Merck KGaA US units agree $44.3 million settlement with DoJ; Ranbaxy faces up to $1 billion fine?

05-05-2011

Four US subsidiaries of German drug major Merck KGaA (MRK: DE) - Serono Laboratories, EMD Serono, Merck…

LegalMerck KGaAMerck SeronoNorth AmericaPharmaceuticalRanbaxy LaboratoriesRebif

USA’s FDA and FTC act to remove fraudulent STD products from the market

05-05-2011

The US Food and Drug Administration has joined forces with the Federal Trade Commission in a joint effort…

North AmericaPharmaceuticalRegulationReproductive

US shortages of key drugs are endangering patients

04-05-2011

In the USA, doctors, hospitals and federal regulators are struggling to cope with an unprecedented surge…

Markets & MarketingNorth AmericaPharmaceutical

US FDA clears Boehringer and Lilly’s diabetes drug Tradjenta

04-05-2011

The US Food and Drug Administration has approved Tradjenta (linagliptin), for use along with diet and…

Boehringer IngelheimDiabetesEli LillylinagliptinNorth AmericaPharmaceuticalRegulationTradjenta

Johnson & Johnson unit voluntarily withdraws NDA for trabectedin

03-05-2011

Centocor Ortho Biotech Products, a division of US health care giant Johnson & Johnson (NYSE: JNJ), says…

Centocor Ortho BiotechJohnson & JohnsonNorth AmericaOncologyPharmaceuticalRegulationtrabectedinYondelisZeltia

Takeda’s Millennium files two sNDAs for Velcade with US FDA

28-04-2011

Japan’s largest drugmaker, Takeda Pharmaceutical (TSE: 4502), together with its US oncology subsidiary…

BiotechnologyMillennium PharmaceuticalsNorth AmericaOncologyPharmaceuticalRegulationTakeda PharmaceuticalsVelcade

US FDA not ready to approve Eisai Aricept Patch; Lipacreon and Halaven OKed in Japan

27-04-2011

Japanese drug major Eisai (TYO: 4523) says that the US Food and Drug Administration has issued a Complete…

AriceptAsia-PacificEisaiHalavenLipacreonNeurologicalNorth AmericaOncologyPfizerPharmaceuticalRegulation

AstraZeneca and Pozen sue Dr Reddy’s over Vimovo patent

27-04-2011

Anglo-Swedish drug major AstraZeneca (LSE: AZN and USA-based Pozen (Nasdaq; POZN) have filed a law suit…

Anti-Arthritics/RheumaticsAstraZenecaDr Reddy's LaboratoriesGenericsLegalNorth AmericaPatentsPharmaceuticalPozenVimovo

New biopharma firm to accelerate vaccines and protein therapeutics delivery

27-04-2011

USA-based Caliber Biotherapeutics has announced the opening of the world's largest plant-made pharmaceutical…

Antibiotics and Infectious diseasesBiotechnologyCaliber BiotherapeuticsMarkets & MarketingNorth AmericaOncologyPharmaceuticalVaccines

AstraZeneca debuts vandetanib for medullary thyroid cancer in USA

26-04-2011

Anglo-Swedish drug major AstraZeneca (LSE: AZN) said yesterday that its orphan drug vandetanib is now…

AstraZenecaMarkets & MarketingNorth AmericaOncologyPharmaceuticalRare diseasesvandetanibZactima

1883 to 1898 of 1898 results

Back to top